newsfilter
← Latest News
GlobeNewswire·

Femasys Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ATLANTA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to women worldwide,